The spread of disease in many cancers has been linked to the expression of EMT transcription factors, which lead to an invasive phenotype characterized by low expression of epithelial marker E-cadherin (CDH1) and high expression of mesenchymal markers Vimentin (VIM) and N-cadherin (CDH2). This evidence concerns the gene CDH1 and cancer.